The Impact of a Topical Vasodilating Cream on FemaleSexual Experience (TVConFSD)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01078077
Verified March 2012 by Michael Pelekanos MD, East Suburban Ob Gyn. Recruitment status was: Recruiting
The purpose of this study is to determine if a topical vasodilating cream will improve femalesexual experience.
Condition or disease
To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
25 Years to 60 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Sexually active females from ages 25 to sixty not on SSRI's without neurologic disease able sign and understand informed consent
Healthy females ages 25 to sixty sexually active
Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent